Cancer Family

Endocrine Neoplasm

Non-malignant762 active trials16 approved drugs64 evidence items

NCIt: C3010

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (60)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 26–50 of 60 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Clinical correlation of extensive-stage small-cell lung cancer genomics.
· Ann Oncol · 2016 · PMID 26802149 · validated civic_curation pubmed
O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors.
· Clin Cancer Res · 2009 · PMID 19118063 · validated civic_curation pubmed
Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization.
· Mol Cell Endocrinol · 2015 · PMID 25448848 · validated civic_curation pubmed
Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancer.
· Lung Cancer · 2015 · PMID 25601188 · validated civic_curation pubmed
Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib.
· Case Rep Oncol · 2014 · PMID 24987354 · validated civic_curation pubmed
Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy.
· Cancer Discov · 2014 · PMID 24934408 · validated civic_curation pubmed
Selective RET kinase inhibition for patients with RET-altered cancers.
· Ann Oncol · 2018 · PMID 29912274 · validated civic_curation pubmed

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies.

· J Thorac Oncol · 2020 · PMID 31988000 · validated civic_curation pubmed

Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma.

· N Engl J Med · 2015 · PMID 26466009 · validated civic_curation pubmed

BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy.

· Cancer Discov · 2016 · PMID 27048246 · validated civic_curation pubmed

Follicular thyroid carcinoma with NRAS Q61K and GNAS R201H mutations that had a good (131)I treatment response.

· Endocrinol Diabetes Metab Case Rep · 2016 · PMID 26788326 · validated civic_curation pubmed

Application of genomics to identify therapeutic targets in recurrent pediatric papillary thyroid carcinoma.

· Cold Spring Harb Mol Case Stud · 2018 · PMID 29610391 · validated civic_curation pubmed

An impressive response with larotrectinib in a patient with a papillary thyroid carcinoma harboring an SQSTM1-NTRK1 fusion.

· Eur J Endocrinol · 2022 · PMID 35118995 · validated civic_curation pubmed

Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC).

· Mod Pathol · 2020 · PMID 32457407 · validated civic_curation pubmed

MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinoma.

· J Clin Endocrinol Metab · 2015 · PMID 25625803 · validated civic_curation pubmed

Germline mutations in the vhl gene in patients presenting with phaeochromocytomas.

· Int J Cancer · 1998 · PMID 9663592 · validated civic_curation pubmed

Paraganglioma in a 13-year-old girl: a novel SDHB gene mutation in the family?

· Cancer Genet Cytogenet · 2010 · PMID 20193854 · validated civic_curation pubmed

RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases.

· Oncotarget · 2018 · PMID 29515777 · validated civic_curation pubmed

Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor.

· Cold Spring Harb Mol Case Stud · 2019 · PMID 31160355 · validated civic_curation pubmed

NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.

· Mod Pathol · 2020 · PMID 31375766 · validated civic_curation pubmed

CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib.

· Cancer Res · 2017 · PMID 28490518 · validated civic_curation pubmed

Anti-tumor activity of motesanib in a medullary thyroid cancer model.

· J Endocrinol Invest · 2012 · PMID 21422803 · validated civic_curation pubmed

AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines.

· PLoS One · 2012 · PMID 23056499 · validated civic_curation pubmed

AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer.

· Cancer Discov · 2014 · PMID 24893891 · validated civic_curation pubmed

Scarpa et al. Nature 2017

· 2017 · PMID 28199314 · validated cbioportal_study pubmed